Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 39.20 | 9.44 |
| PEG Ratio (TTM) | 0.58 | -1.42 |
| P/S Ratio (TTM) | N/A | 7.15 |
| P/B Ratio (TTM) | N/A | 34.72 |
| P/FCF Ratio (TTM) | N/A | 17.38 |
| Price to 5YR AVG Earnings Ratio | -1.09 | -2.67 |
| Price to 5YR AVG FCF Ratio | 0.57 | 59.43 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 0.09% |
| ROE (TTM) | N/A | -141.70% |
| Net Profit Margin (TTM) | 7.18% | 1.47% |
| ROIC 5YR AVG | 9.60% | 31.54% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 326.99% | 66.18% | 34.06% |
| Revenue | -2.90% | 626.87% | 8,367.70% |
| Net Income | 306.00% | -48.42% | 11.27% |
| Cash Flow | 47.38% | -454.92% | 118.85% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 2.65 |
| Quick Ratio (TTM) | N/A | 2.64 |
| D/E Ratio (TTM) | N/A | 0.80 |
| Interest Coverage (TTM) | N/A | 1.25 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | N/A | 4.45 |
| LTL to 5YR AVG FCF | 3.78 | 3.88 |
| Shares Outstanding Growth 5YR AVG | 2,840.09% | 7.01% |